share_log

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

富國銀行將Celldex Therapeutics上調至同等權重,宣佈目標股價27美元
Benzinga ·  2023/11/10 19:27

Wells Fargo analyst Derek Archila upgrades Celldex Therapeutics (NASDAQ:CLDX) from Underweight to Equal-Weight and announces $27 price target.

富國銀行分析師德里克·阿奇拉將Celldex Therapeutics(納斯達克股票代碼:CLDX)從減持上調至同等權重,並宣佈了27美元的目標股價。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論